INTRODUCTION
T herapeutic drug monitoring (TDM) was introduced in the early 1970s with the objectives of improving the patient safety, individualize the dosage regimen and surmount the systemic toxicity. In general, clinical tests are performed very frequently to determine the drug concentration in the body during the therapy. Essentially, TDM is highly required for drugs possessing narrow therapeutic index as a slight variation in the therapeutic range could result in no or low clinical effi ciency or causes signifi cant side eff ects or high risk of toxicity [1] . However, the existing methods for drug collection such as blood sampling fromvein (venipuncture) and fi nger stick method is highly invasive and possess low patient compliance especially when the sampling frequency is much high .
Recently, research has been focused on non-invasive methods to monitor the drug plasma concentration. In this contest, skin provides a unique gateway for noninvasive transdermal drug monitoring. Th e application of electric current across the skin could be used to extract the endogenous molecules within or beneath the skin [2] . In recent days, reverse iontophoresis technique has been attempted for the non invasive drug monitoring. Typically, it applies a low electric current through a pair of skin electrodes to promote the transport of both charged and neutral molecules [3] . Several in vitro and in vivo studies have demonstrated the potential of reverse iontophoresis to monitor the sub dermal concentration of drugs and other biomolecules [4] [5] [6] [7] [8] [9] [10] . Th e development of biosensors have replaced the old technology of drug analysis from the extraction chamber and made novel devices which are portable and more convenient. One of the most successful applications of reverse iontophoresis till today is the noninvasive glucose monitoring employing the Glucowatch. Th is article discusses the basic principles and the recent developments on reverse iontophoresis in therapeutic drug monitoring.
THERAPEUTIC DRUG MONITORING
Maintaining the therapeutic concentration is not easy as several factors such as ADME could infl uence or alter the systemic drug availability. Further the monitoring is very necessary for vulnerable patient populations (neonates and geriatric) wherein a slight variation of drug concentration can likely to causes immediate adverse eff ects. It helps in the individualization of dosage by maintaining plasma blood concentration and thereby avoidsvariation in the pharmacokinetic and pharmacodynamic activities. Typically, TDM involves the measurement and interpreting drug concentrations in biological fl uids (usually serum) and applying well-described pharmacokinetic and pharmacodynamic principles of the drug to optimize a treatment regimen for an individual patient. Since the initiation of this service, diff erent studies evaluating TDM laboratory activities, studying the impact of the service on patient outcome, surrogate endpoints, and pharmacoeconomic evaluations have been done worldwide [11] . Th erapeutic drug monitoring is very essential for the drugs which exhibit specifi c characteristics such as narrow therapeutic index, concentration related therapeutic and adverse eff ects, noticeable pharmacokinetic variation, distinct therapeutic concentration range, desired therapeutic eff ect diffi cult to monitor. TDM is considered to be most useful if there is a good correlation between the concentration of the drug and its therapeutic eff ect. In pediatric patients TDM establishes a reference for the treatment of epilepsy. Determination of carbamazepine concentrations in children helps in avoiding toxicity. Further, the determination of phenytoin concentration in older patients plays a key role. TDM is performed due to the reason that certain drugs have short therapeutic index; the concentration above the range causes toxicity and below the range causes ineff ectiveness [12] .Th ere are situations wherein it is diffi cult in diff erentiating the disease condition and side eff ects of drug. In these conditions, TDM provides adequate information to decide the dosage regimen. Th ere are also other cases in which TDM plays a major role, some of them are as follows.
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Patients taking chemotherapy of cancer •
In case of infants • Changing the dose or formulation • Changing concomitant medication • Most of the drugs which are therapeutically monitored are taken for lifetime [11] . Th e steady state concentrations of these drugs must be maintained as there is increase in age of patients and also conditions like pregnancy, infections, accidents and diseased state aff ects the drug interaction in the body. It is likely that the TDM could provide the variation in drug concentration in the body and could help in modify the dosage regimen. Further, the noncompliance of the patients can be identifi ed by TDM and can tailor the dosages to suit the patients. Th ere are different classes of drugs which are monitored routinely and are listed in Table 1 .
EXTRACTION OF DRUGS
Skin is the largest organ of the body with an area of approximately 2m 2 , and provides a comprehensive and accessible surface for drug extraction from the subdermal region. Th e stratum corneum, outermost layer of skin, composed of dead, fl at skin cells and is mainly responsible for its barrier function. Several physical and chemical approaches have been developed to compromise this formidable barrier although very few could fi nd their way [13, 14] . Among the methods developed, iontophoresis is found to be most promising approach and has been widely studied. Iontophoresis evolved as a transdermal enhancement technique in the 20th century, primarily for the delivery of large and charged molecules [15] . Signifi cant achievements have been made in the understanding of underlying mechanisms of iontophoresis and these have contributed to the rational development of iontophoretic delivery systems. Basically, transdermal iontophoresis apply a small electrical current (0.1-0.5 mA/cm 2 ) to the skin in order to increase the percutaneous molecular transport. Th is technique has found its applications in the fi eld of transdermal drug delivery and several iontophoretic drug delivery systems have reached the market. Th e success of transdermal iontophoresis leads the drug delivery scientists to focus on the feasibility of iontophoretic extraction (reverse iontophoresis) of molecules from the body rather than its forward iontophoreticdelivery into the body. Further, the symmetry of iontophoresis is such that it is possible to deliver molecules into the body and could also be extracted. In principle, reverse iontophoresis causes extraction of solute molecules from sub dermal parts to skin surface [16] . Th e technical description of this process is a non-invasive method of expelling charged drug across the skin by repulsive electromotive force using a small electrical charge applied to an iontophoretic chambers containing vehicle. Drug molecules (charged/uncharged) will be transported from the subdermal region to the electrode by diff erent routes (intracellular, hair follicles and sweat ducts).
Drug extraction from the interstitial fl uid can be achieved by transiting of a low level of a current across the skin usually with couple of skin electrodes involving a conducting base to elevate extraction of charged as well as neutral molecules, by diff erent mechanisms. Th e interstitial fl uid is collected and analyzed using a suitable device.Th is technique can have important applications in medical diagnostics as it can allow non-invasive sampling of endogenous molecules. In reverse iontophoresis, the negative charge of the skin at buff ered pH causes it to be permselective to cations causing solvent fl ow towards the cathode [17] . Th is fl ow is the dominant force allowing movement of neutral molecules, including glucose, across the skin. Th e redox reactions take place at site of electrodes causes charge imbalance at both cathodic and anodic solutions as a result ion migrate to skin to maintain electro neutrality [16] .Th is technique is currently being used in device such as Glucowatch which allows blood glucose detection across skin layers using reverse iontophoresis. However, ions possessing specifi c charges could Table 1 : Drug molecules that necessitate therapeutic drug monitoring.
Categories
Drugs be easily extracted by electro-repulsion [18] . Moreover, it is required that the concentration of compounds extracted from the body is directly related to its sub dermal concentration [19] . Th e major factor which needs to be considered during iontophoresis is the operating current density. In general, the current density of ≤0.5mA/cm 2 is well tolerated in humans. In experimental situations, aqueous solutions/buff ers are used to fi ll electrolyte chambers in which analyte is extracted, while for commercial purposes, the use of gel or polymer is preferred [15, 20] . In addition, the favorable physiochemical properties of a molecule could augment the reverse iontophoretic extraction. Charge, molecular weight, and lipophilicity are critical, and promising results can be expected for small, mobile and hydrophilic drugs. Moreover, it is important to realize that the concentration of the analyte is the variable of interest and will depend on the dosage regimen and the relevant pharmacokinetics.
Th e major challenge of monitoring blood levels of endogenous molecules is the possible contamination from signifi cant analyte amounts in the skin. Th e sensitivity of the analytical procedures determines the minimum length of the iontophoretic sampling period that extracts suffi cient amount of the analyte to allow accurate quantifi cation. Moreover, one should remember that the drug is not extracted from the blood but it is from the skin tissues, thus represents the subdermal drug concentration. Iontophoresis fl uxes of extraction are proportional to the analyte concentration in the subdermal interstitial fl uid and their information about plasma levels will depend on the rapidity with which the equilibrium plasma interstitial fl uid levels are established. Hence, requirement of suffi cient analyte in the subdermal concentrations is essential for the successful transport and extraction of measurable amount of drug transport across the skin during reverse iontophoresis. Th is is not only challenging in the case of endogenous molecules, but also for the monitoring of drugs, especially if they are protein bound [21] .Th is was demonstrated in the case of highly protein bind drug such as valproic acid and phenytoin. Th e authors observed that the addition of protein (albumin) to the subdermal solution reduced the drug extraction [20, 21] . Hence, it is likely that that only the free drug will be transported across the skin as the protein bound form is too large to be extracted.
A successful application of reverse iontophoresis in therapeutic drug monitoring clinically has so far been demonstrated for lithium, a small, non protein bound positively charged ion. It possesses high mobility and competes to transport charge across the skin much more effi ciently than most therapeutic drugs. Moreover, the plasma concentration of lithium is also much high. Accordingly, the amounts detected at the skin surface can be easily assayed with existing technology.
Issues with reverse iontophoresis in drug monitoring continued with related to multiple aspects. Th e foremost issues including the requirement of complicated technology, relatively long warm-up time, and calibration with ablood sample etc. Secondly, issues related to skin (erythema, edema), incorrect observations during sweating and high cost has also limited the success of this technology. However, the snags of this technology have been rectifi ed to some extent. Th e major issues such as invasive calibration have been avoided by doing the simultaneous extraction of a known internal standard [22] . Th e basic principle involved here is the subdermalconcentration of the analyte of interest can bepredicted solely from ratio of extracted fl uxes of theanalyte and internal standard. Th is has been demonstrated in various studies using diff erent analytes including amikacin, valproic acid, lactate, phenytoin and lithium [20] [21] [23] [24] [25] [26] . However, the challenges still remain with neutral molecules such as glucose. On the other hand, the skin may also accumulate the drug and produces a specifi c drug reservoir, which might be extracted in the initial stage of the reverse iontophoresis and may leads to false results. Th e possible option to surmount this issue could be excluding the data in the initial period, during which the drug in the skin tissues will be extracted.
TRANSPORT MECHANISMS
Several reviews on the mechanisms of transport underlying iontophoresis and its applications for drug delivery are available elsewhere [15] . Iontophoresis is considered as a symmetric process, which means that molecules within the subdermal compartment can be extracted to the skin surface. Th e mechanism of reverse iontophoresis is as similar to iontophoresis, based on the principles of charges (i.e., like charges repel each other). An electrode with a defi ned charge is used to repel a drug with a similar charge, which is attracted by an oppositely charged electrode placed elsewhere on the body. Briefl y, both electromigration and electroosmosis contribute to iontophoretic transport, allowing sampling of both charged and neutral molecules. Th e increased fl ux during iontophoresis would include, fl ux due 
where J electric is the fl ux due to electric current application and J convective is the fl ux due to convective transport due to electroosmosis.
In electromigration, there is direct encounter between applied fi eld and charged ion [27] [28] [29] . Th e power source maintains an electric fi eld that causes migration of electrons in the electrical compartment of skin and ion starts to fl ow in the ionic parts. According to the total number of electrons passing the electrical compartment is totally balanced by the quantity of charge passing through the body [30] . Ionic transport maintains electro-neutrality by passing through the body [31, 32] .
Faraday's law can be used to relate the ionic transport (either inward or outward) crossing the membrane to the intensity of the electric current applied, the time of current passage, and the charge per ion. It is important to realize that all the ions present at both sides of the skin compete to transport charge during iontophoresis.
Under the infl uence of a direct constant current, drug fl ux (J i -mol/s) is given by
it is small, fully charged, at high concentration, and is not protein bound.
Revere iontophoresis also extracts analytes by electroosmosis. Because skin carries a net negative charge at neutral pH, sodium ions in the interstitial fl uid are major charge carrier through the skin. So the migration of these sodium ions makes a net convective solvent fl ow towards the cathode [33] . Th is solvent fl ow carries along with dissolved solutes allowing the transport of neutral, and especially, polar molecules that are extracted at the cathodal compartment [27] . However, the volume of solvent fl ow is directly proportional to the potential gradient between the electrodes [34, 35] . Th e electroosmosis transport is the basic mechanism underlying the reverse iontophoresis extraction of glucose, a neutral and polar substance. Furthermore, this convective fl ow reinforces the transport of cations while acting against that of anions. Th us, extraction of a cationic analyte will always be easier than that of an anion of similar physio-chemical and pharmacokinetics properties.
STUDIES ON THERAPEUTIC DRUG MONITORING
Th e applications of reverse iontophoresis include general blood chemistry, glucose monitoring, the detection of diagnostic markers, and therapeutic drug monitor- ing. Studies on reverse iontophoresis to extract a variety of compounds are being investigated (Table 2) . Th e use of reverse iontophoresis for noninvasive drug monitoring and pharmacokinetic profi ling has been investigated for valproate, lithium, phenytoin, amikacin, caff eine, theophilline etc. Th e idea of applying reverse iontophoresis to extract molecules from the body was fi rst reported in 1954 by Benjamin et al [36] . A low current density (0.5 mA/cm 2 ) was applied using a metal on humans to extract sodium and potassium ions. In the latter part, Glikfeld et al have extracted three diff erent molecules (clonidine, theophylline, and glucose) by the application of reverse iontophoresis [37] . Further, these molecules possess diff erent properties such as one being a charged cation (clonidine), second one is partially charged anion (theophylline), and third one is a neutral polar molecule (glucose). Th ey observed that the amount of molecules extracted across the skin was linearly correlated to the subdermal concentration, irrespective of the charge they possess.
Th e primary benefi t of using reverse iontophoresis is that the pain and discomfort are reduced and the sampling can be drawn at any moment. Th e samples collected at regular interval could be sent and analyzed in the laboratory, thus provides incessantly monitoring of the sub cutaneous drug concentration. Further, the device used in reverse iontophoresis is miniaturized and can be easily transported, programmable and avoids hospitalization [38, 39] .Th e technique is especially suitable in patients having diffi culty of blood collection very frequently and those comes under specialized treatment like in case of cancer, AIDS, pregnantwomen, pediatric, geriatric and chronically ill individuals. Moreover, this technique could be useful for patients who are immovable and cannot impart problem with side eff ects of drug. In case of preterm infants the therapeutic drug monitoring is quite diffi cult and critical [40] [41] [42] . Blood sampling in this case preferably avoided as it increases risk of infection and fi nding a vein is very diffi cult due to prematurity [43, 44] . In this case reverse iontophoresis could be the only possible option for the regular therapeutic drug monitoring. Th e application of reverse iontophoresis for noninvasive drug monitoring and pharmacokinetic profi ling has been investigated for several molecules including valproate, lithium, phenytoin, amikacin, caff eine, and theophylline. Th e data observed form these studies suggests that iontophoresis can effi ciently and noninvasively sample drugs of appropriate physicochemical and pharmacokinetic properties, perform drug monitoring and provide an estimation of the elimination (terminal) rate constant.
Th is technique could be utilized to assess the sub dermal concentration of charged and uncharged molecules by electromigration or electroosmosis [45, 46] . Moreover, the transport of these molecules is controlled by continuity and level of applied current. Th e evolution of sensitive and specifi c analytical tools which detects compound more precisely has extended the application of reverse iontophoresis. Although, the reverse iontophoresis is much effi cient in extracting the solutes, the quantity of anlaytes could cross the skin layer is much low (10-1000 times lower than the subdermal concentration). However, the availability of sophisticated and sensitive analytical methods could overcome this issue.
Attention was focused on glucose for the application in glucose monitoring in diabetes. Th is approach carries an immense medical benefi t for the noninvasive, continuous measurement of glucose, by increasing the frequency of measurements compared to conventional methods, and by avoiding invasive procedures to collect a blood sample or to place an implantable glucose sensor into the subcutaneous tissue. Several investigations have leads to the optimization of parameters for the reverse iontophoresis of glucose. In vitro and in vivo reverse iontophoresis experiments in non-diabetic subjects were promising and further research eff orts led to the commercial development of the Glucowatch Biographer [47] . Th e principle involved in this device is the transport of glucose (neural molecule) by electroosmosis and is proportional to the applied current. Th e glucowatch biographer utilizes execution of biosensing the amount of glucose transported across the skin layer [47, 48] . Th e potential of glucowatch biosensor was evaluated in 92 human subjects. Clinical results with this device showed close tracking of blood glucose over a period of 12 h and a good correlation between glucowatch biographer reading and blood glucose was observed, although the biographer reading lag behind blood glucose level values by 18 min. Th e study concluded that the automatic, frequent, and non invasive measurement obtained with the glucowatch biographer provide substantially more information about glucose levels than the fi ngerstick method [3] . In another attempt, the precision and accuracy of the glucowatch (automated glucose biographer) was evaluated in 19 patients suff ering from type 1 and type 2 diabetes mellitus. Th e glucose level was checked and compared with anticubital venous blood samples. Th e data observed indicate that the glucose concentration in both the methods were comparable [47] . Recently, attempts were made to develop a glucose biosensor based on carbon nanotubes material for reverse iontophoresis and was fabricated by immobilizing a mixture of glucose oxidase and multiwalled carbon nanotubes epoxy-composite, on a planar screen-printed carbon electrode [48] .
Th e success of the reverse iontophoresis extraction technique in clinical studies has inspired various groups of research scientists and became the topic of current research.To extend the application of this technique, severalendogenous molecules such as lithium, urea, prostaglandin, lactate,phenylalanine, amino acids etc have been investigated.
Lithium, used to treat bipolar disorders, a low molecular weigh cationic molecule having a higher eff ective plasma concentration. In vitro studies were carried out to assess the feasibility of extracting this molecule. Th e results observed indicated excellent correlation and rapid extraction from a physiological buff er [49] . Studies were also carried out in bipolar patients showed the potential of reverse iontophoresis as a useful clinical tool for noninvasive monitoring of this drug. Monitoring of lithium was carried out in vivo by reverse iontophoresison 24 humans, using one arm as standard and other for test (area ~3.2 cm 2 ). Th e results indicated effi cient extraction of lithium from the sub dermal region. An excellent relationship between the extracted sample and serum concentration was reported [25] .
Monitoring of urea in plasma could be used to investigate the kidney failure in patients with diabetes and hypertension [50] . In vivo studies were carried out in humans with impaired kidney function. Th e urea fl ux extracted by reverse iontophoresis was well correlated (r 2 =0.88) with analyte sub dermal levels and these are susceptible to time dependent changes in concentration.Wascotte et al optimized the procedure to monitor urea, in vitro and in vivo in healthy volunteers and patients with chronic kidney disease. Two cylindrical shaped glass cylinders was attached to each person's forearm using silver-silver chloride electrode placed at 5 mm from surface of skin. A current intensity of 0.8 mA (for 2 h) was applied and samples were drawn and analyzed at every 30 min. Th e results were found to be promising as the extracted urea fl uxes were diminuted with respect to time, both in healthy persons and patient of chronic kidney disease. Th e preliminary study demonstrated that monitoring of urea could be possible by the revere iontophoresis [50] . Studies were also carried out to monitor urea and potassium using porcine ear skin. Reverse iontophoresis was carried out for 6 h and the drug samples from the cathode chamber was analysed. Th e data observed indicated a good correlation between the sub dermal drug concentration and the amount of urea and potassium extracted [51] . Th e development of noninvasive techniques to monitor renal function would result in an improved therapy and a better quality of life for the patient [50] .
Noninvasive lactatemia monitoring is of interest in the ease of critically ill patients as well as a marker of performance in sports training. Lactate, a relatively concentrated, small anion, constitutes a good candidate for reverse iontophoretic extraction. In fact, it is easily and rapidly extracted both in vitro and in vivo. Th e simultaneous in vivo extraction of chloride, and its possible role as an internal standard to calibrate lactate reverse iontophoretic fl uxes, was also demonstrated [52] . In another attempt, extraction of lactate was attempted by reverse iontophoresis with the objective of determining the organ failure. Studies were carried out in 10 humans using screen printed electrodes coated with methyl cellulose gel. Th e gel was extracted and the lactate content was assessed and compared with the plasma lactate level. Th e results indicated a fair correlation [26] .
Attempts were also made to extract diff erent amino acids by reverse iontophoresis. Several in vitro and in vivo studies demonstrated that most amino acids could be extracted by reverse iontophoresis and could be analysed by the existing analytical techniques. Th e charged species were extracted in the opposite electrodes while the zwitter ionic species were extracted at both electrodes. Th e results indicated that the reverse iontophoresis have the potential of extracting diff erent amino acids and can provide a reliable correlation [53] . Rapid extraction of amino acids by reverse iontophoresis after tape stripping was demonstrated [54] . Application of reverse iontophoresis was explored by assessing the feasibility of extracting phenylalanine an amino acid used to diagnose Phenylketonuria (metabolic disease in infants). Th e extraction was found to be rapid, easily detectable and linear (1-10 mM)correlation was observed between the amount of phenylalanine extracted and sub dermal concentration. In practice, this could provide much advantage in early detection of a metabolic disorder namely phenylketonuria [17] .
In another study, the potential of reverse iontophoresis in extracting theophylline and caff eine was assessed using novel model which bear a resemblance to cutaneous barrier of neonate.Studies were carried out in full thickness and tape stripped porcine skin in vitro. Th e electric potential was applied for 5 h and the amount of drug extracted was assessed every hour using HPLC. Th e results indicated signifi cant drug extraction following iontophoresis, suggesting the possibility of this technique to extract theophylline and caff eine [43] .
Phenytoin, an antiepileptic drug possesses a very narrow therapeutic drug concentration. An investigation was carried out to extract phenytoin from the subdermal concentration, by reverse iontophoresis for monitoring of free drug in the body. Eff ect of drug concentration, protein concentration etc were investigated. Experiments were conducted in vitro using porcine ear skin using vertical diff usion cell. Th e results indicate that the extraction effi ciency was infl uenced by change in protein concentration and drug concentration. However, the observation from this study points to the fact that the monitoring of phenytoin is very much possible using reverse iontophoresis [21] . Similarly, the technique of reverse iontophoresis for therapeutic drug monitoring was explored for valprioc acid as well. Studies were carried out to extract valproate, along with an internal standard (glutamate), in vitro. A constant current was applied for 5 h and the samples were withdrawn and analyzed. Th e results were found to be promising and a linear regression shows that correlation in-between fl uxes and subdermal levels [20] .
Th e application of reverse iontophoresis has been extended as a diagnostic tool. Mize et al have monitored the prostaglandin E 2 in guinea pig by reverse iontophoresis, after inducing infl ammation by regular transdermal iontophoresis of irritant drug compounds. Th e amount of PGE 2 extracted on the anodal surface was monitored by radio immune assay. Th e study concludes that the prostaglandin E 2 generated in response to transdermally applied drug irritants can be monitored by reverse iontophoresis [56] .
Reverse iontophoresis of amikacin was carried out across rabbit skin in vitro by applying a constant current of 0.5 mA/cm 2 for a period of 2 h. Th e amount of amikacin extracted across the skin at the cathode showed linear correlation with increase in time. Th is observation indicates that amikacin could be eff ectively extracted by reverse iontophoresis, and required further optimization [23] .
CONCLUSION
Extensive study results suggest that reverse iontophoresis can effi ciently and noninvasively sample analytes with the appropriate characteristics. Recent development in reverse iontophoresis substantiated its potential in the therapeutic drug monitoring. Th e development of glucowatch has established its great potential in the fi eld of monitoring of glucose. Development of this method provides a great care for the diabetic patients. Th e importance of this device is greatly recognized not only for research purpose but also in other methods by which there will be an improvement in patient care and reduction in pain, discomfort. Few practical challenges remain to be resolved before this technology can be implemented for widespread use. Th erapeutic drug monitoring can be accomplished by reverse iontophoresis and it is believed that in the future it will be proved as reliable in terms of miniaturization, sensitivity, specifi city.In upcoming time, this method will be one of best noninvasive method that will be employed for monitoring of compounds in the body and likely to replace the process of blood sampling.
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